Friday, September 2, 2016
BJ Towe

The Pappajohn Entrepreneurial Center's Venture School helps bring academic discoveries to market, including that of Immortagen, whose mission is to move cancer treatment from a one-size-fits-all approach to truly personalized care based on a tumor's molecular composition. Read more in this Des Moines Register article.